Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population
Titel:
Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population
Auteur:
Ciruelos, E. Jerusalem, G. Martin, M. Tjan-Heijnen, V. C. G. Neven, P. Gavila, J. Montemurro, F. Generali, D. Lang, I. Martínez-Serrano, M. J. Perelló, M. F. Conte, P.